reading time

Tekcapital Share Price

Tekcapital PLC operates through various subsidiary companies, including Lucyd Ltd., Salarius Ltd., Belluscura Ltd., and Origen Biomedical Ltd. These subsidiaries are engaged in different sectors, such as augmented reality (AR) glasses, low-sodium salt, portable oxygen concentrators, and medical devices.

Tekcapital Share Price

Tekcapital PLC is a technology transfer company based in the United Kingdom. They focus on commercializing intellectual property (IP) and technologies developed by universities and research institutions. The company aims to identify promising IP, acquire or license its rights, and develop it into commercial products or services. As of this post, the Tekcapital Share Price is 12.59 GBX.

Tekcapital Share Price

Brief Background of Tekcapital Share Price

Tekcapital PLC (LSE: TEK) is a technology transfer company on the London Stock Exchange. While I cannot access real-time stock data, I can provide a brief overview of the company’s historical milestones up until September 2021.

Tekcapital was founded in 2013 Clifford M. Gross and Malcolm G. Groat to commercialize intellectual property (IP) from universities and research institutions. The company’s initial public offering (IPO) occurred on the London Stock Exchange’s AIM market in June 2014.

In the years following its IPO, Tekcapital acquired several subsidiary companies to expand its IP portfolio and commercialization efforts. Some notable acquisitions include:

  1. Guident Ltd: Acquired in November 2014, Guident is a patented technology for navigating uncrewed aerial vehicles (UAVs) using augmented reality (AR) glasses.
  2. Lucyd Ltd: Acquired in June 2017, Lucyd is a developer of AR eyewear and smart glasses technology.
  3. Salarius Ltd: Acquired in August 2017, Salarius focuses on low-sodium salt production for the food industry.
  4. Belluscura Ltd: Acquired in July 2018, Belluscura specializes in portable oxygen concentrators for medical applications.

Tekcapital Share Price has invested strategically in various technologies and IP assets through subsidiary companies.

Advantages of Investing in Tekcapital Share Price

These advantages are based on general observations and may not reflect the current situation or prospects of Tekcapital’s Share Price.

Technology Transfer and IP Portfolio

Tekcapital Share Price focuses on technology transfer and acquiring intellectual property (IP) from universities and research institutions. This approach allows them to tap into potentially innovative and valuable technologies. If successful in commercializing these technologies, it could lead to revenue growth and provide an advantage over competitors.

Diversification

Tekcapital Share Price operates through various subsidiary companies involved in different sectors, such as augmented reality (AR) glasses, low-sodium salt, portable oxygen concentrators, and medical devices. This diversification may help mitigate risks associated with heavily reliant on a single industry or technology.

Growth Potential

The successful commercialization of IP and technologies could lead to revenue growth and increased market value for Tekcapital’s Share Price. In addition, if the company’s portfolio companies achieve significant milestones or secures valuable partnerships, it may positively impact the stock’s performance.

Market Demand

Some of Tekcapital Share Price’s subsidiary companies operate in sectors with potentially high market demand. For example, the demand for AR glasses, low-sodium salt alternatives, and portable medical devices could be driven by consumer preferences and regulatory changes. Meeting these market demands successfully could position Tekcapital’s Share Price for growth.

Main Competitors of Tekcapital Share Price

  1. Intellectual Property Management Companies: Companies such as Tech Transfer Central, RTTP (Registered Technology Transfer Professional) organizations, and other IP management firms focus on assisting universities and research institutions with IP commercialization. These entities may compete with Tekcapital in identifying, acquiring, and managing IP.
  2. Technology Licensing and Commercialization Firms: Various firms specialize in licensing and commercializing technologies developed by universities and research institutions. Examples include IP Group, Allied Minds, and Oxford Sciences Innovation. These firms may compete with Tekcapital in acquiring and developing IP into commercial products or services.
  3. In-house Technology Transfer Offices: Many universities and research institutions have their own technology transfer offices, which are responsible for identifying, protecting, and commercializing their intellectual property. These offices often work directly with industry partners to license or spin-off technologies. While not direct competitors, they play a significant role in the technology transfer ecosystem.
  4. Venture Capital and Private Equity Firms: Venture capital and private equity firms focusing on early-stage technology investments may indirectly compete with Tekcapital by investing in startups or companies with innovative technologies. These firms often provide funding and expertise to help startups develop and commercialize their IP.

 

The Best Copytrading Platform

UK - NSBroker
★★★★★
Minimum deposit 250 USD
Regulated in Europe
Trade selections Stocks, Indices, Crypto
  • Tight spreads & no commission

  • Advanced trading platform

  • Real-time market execution

eToro UK
★★★★★
Minimum deposit 200 USD
Regulated in Europe
Trade selections Forex, Crypto, Stocks, Commodities, ETFs, Indices
  • Zero Commissions on Trades

  • CopyPortfolios/Copytrade Feature

  • Ask Experts Questions

  • Wide Range of Stocks

Conclusion

Tekcapital PLC is a technology transfer company that commercializes intellectual property (IP) from universities and research institutions. The company’s performance can be influenced by various factors, including its ability to identify and acquire valuable IP, successfully develop and commercialize technologies, establish partnerships and collaborations, and generate revenue from licensing or selling IP.

FAQ

FAQ: Tekcapital Share Price

Does Tekcapital PLC pay dividends?

Tekcapital PLC had not historically paid dividends.

Who are the target investors of Tekcapital PLC?

Institutional Investors: These are typically large investment firms, such as pension funds, mutual funds, and insurance companies, which invest on behalf of their clients or beneficiaries. Institutional investors often have significant capital to allocate and may seek long-term investments that align with their investment strategies.

Retail Investors: Individual investors purchase company shares through brokerage accounts. Retail investors may be attracted to Tekcapital's investment potential, growth prospects, or industry-specific interests.

Venture Capital and Private Equity Firms: Tekcapital may target venture capital and private equity firms specializing in early-stage technology investments. These firms often provide capital, expertise, and strategic guidance to help companies grow and succeed.

Impact Investors: Impact investors are individuals or organizations that seek to generate positive social or environmental impact alongside financial returns. Tekcapital's focus on commercializing technologies developed by universities and research institutions may attract impact investors looking to support innovation and technology transfer.

Strategic Partners: Tekcapital may also target strategic partners or companies in related industries interested in accessing or licensing its portfolio's intellectual property (IP) or technologies. These partners may bring additional expertise, resources, or market access to support Tekcapital's growth.

What is the moat of Tekcapital PLC?

Intellectual Property (IP) Portfolio: Tekcapital specializes in acquiring and commercializing intellectual property from universities and research institutions. The company's extensive IP portfolio could provide a competitive advantage by offering unique and valuable technologies that may be difficult for competitors to replicate or access.

Network and Relationships: Tekcapital's established relationships with universities, research institutions, and other stakeholders in the technology transfer ecosystem could be a source of competitive advantage. These networks and partnerships may provide access to a pipeline of innovative technologies and potential collaboration opportunities.

Expertise and Experience: Tekcapital's team likely possesses expertise in intellectual property management, technology transfer, and commercialization. Their experience and knowledge in identifying promising technologies, evaluating market potential, and navigating the IP landscape could contribute to their competitive advantage.

Diversification: Tekcapital's subsidiary companies operate in various sectors, such as augmented reality, medical devices, and food technology. Diversifying across multiple industries may help mitigate risks and provide resilience to changes in specific markets or technologies.

Rate this post
Simon Williams
Latest posts by Simon Williams (see all)